XML 16 R3.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 3,213,376 $ 2,951,422
Marketable securities—available-for-sale (amortized cost $442,816 and $292,580 as of December 31, 2023 and 2022 respectively; allowance for credit losses $0 as of December 31, 2023 and 2022) 442,667 287,543
Accounts receivable 743,557 644,879
Inventory 62,972 41,995
Prepaid expenses and other current assets 182,830 167,011
Total current assets 4,645,402 4,092,850
Restricted cash 1,845 1,698
Long term investments 187,716 133,676
Inventory 206,965 78,964
Property and equipment, net 751,513 739,310
Finance lease right-of-use assets, net 25,535 26,298
Other intangible assets, net 123,545 129,219
Goodwill 155,593 155,593
Deferred income tax asset 631,886 457,941
Other assets, net 52,107 25,435
Total assets 6,782,107 5,840,984
Current liabilities:    
Accounts payable 109,601 277,546
Accrued compensation 153,348 138,761
Accrued and other current liabilities 935,569 701,053
Finance lease liabilities 3,439 3,179
Acquisition-related contingent consideration 38,422 36,538
Total current liabilities 1,240,379 1,157,077
Acquisition-related contingent consideration 173,578 184,462
Finance lease liabilities 29,162 30,083
Other liabilities 149,151 99,243
Total liabilities 1,592,270 1,470,865
Commitments and contingencies (Note 16)
Stockholders’ equity:    
Preferred stock, $0.001 par value; 5,000,000 shares authorized; none issued or outstanding as of December 31, 2023 and 2022 0 0
Common stock, $0.001 par value; 400,000,000 shares authorized; 224,286,862 and 222,746,719 shares issued and outstanding as of December 31, 2023 and 2022, respectively 224 223
Additional paid-in capital 5,016,122 4,792,041
Accumulated other comprehensive income 13,106 15,069
Retained earnings (accumulated deficit) 160,385 (437,214)
Total stockholders’ equity 5,189,837 4,370,119
Total liabilities and stockholders’ equity $ 6,782,107 $ 5,840,984